Osmotics Corp

All filings by Osmotics Corp on record concern Ceragenix Pharmaceuticals, Inc. Over a trading history stretching from 11 May 2006 to 9 March 2010, the count stands at 8 filings.

In open-market terms, that means 1 purchase on one side and 7 sales worth €377k on the other. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2010, the count stands at no purchases and 1 sale.

The newest entry dates from 11 March 2010: an open-market sale of €11k, in Ceragenix Pharmaceuticals, Inc. The last insider purchase was made public on 19 May 2008, 6,747 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.